Vericel Corp Company Profile (NASDAQ:VCEL)

About Vericel Corp (NASDAQ:VCEL)

Vericel Corp logoVericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment. Its autologous cell therapy products include Carticel (autologous cultured chondrocytes), which is an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:VCEL
  • CUSIP: N/A
  • Web:
  • Market Cap: $137.86 million
  • Outstanding Shares: 32,824,000
Average Prices:
  • 50 Day Moving Avg: $4.86
  • 200 Day Moving Avg: $3.47
  • 52 Week Range: $2.00 - $6.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.05
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $53.77 million
  • Price / Sales: 2.56
  • Book Value: $0.43 per share
  • Price / Book: 9.77
  • EBITDA: ($20,030,000.00)
  • Net Margins: -14.09%
  • Return on Equity: -64.99%
  • Return on Assets: -24.84%
  • Debt-to-Equity Ratio: 0.58%
  • Current Ratio: 2.55%
  • Quick Ratio: 2.31%
  • Average Volume: 754,211 shs.
  • Beta: 3.17
  • Short Ratio: 5.26

Frequently Asked Questions for Vericel Corp (NASDAQ:VCEL)

What is Vericel Corp's stock symbol?

Vericel Corp trades on the NASDAQ under the ticker symbol "VCEL."

How were Vericel Corp's earnings last quarter?

Vericel Corp (NASDAQ:VCEL) announced its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.24) by $0.16. The company had revenue of $16.95 million for the quarter. Vericel Corp had a negative return on equity of 64.99% and a negative net margin of 14.09%. View Vericel Corp's Earnings History.

When will Vericel Corp make its next earnings announcement?

Vericel Corp is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Vericel Corp.

Where is Vericel Corp's stock going? Where will Vericel Corp's stock price be in 2017?

3 equities research analysts have issued 12-month price objectives for Vericel Corp's shares. Their predictions range from $6.00 to $7.00. On average, they anticipate Vericel Corp's share price to reach $6.33 in the next twelve months. View Analyst Ratings for Vericel Corp.

Are investors shorting Vericel Corp?

Vericel Corp saw a decline in short interest during the month of September. As of September 15th, there was short interest totalling 1,182,214 shares, a decline of 23.5% from the August 31st total of 1,545,126 shares. Based on an average trading volume of 453,340 shares, the days-to-cover ratio is currently 2.6 days. Currently, 3.6% of the company's shares are sold short.

Who are some of Vericel Corp's key competitors?

Who are Vericel Corp's key executives?

Vericel Corp's management team includes the folowing people:

  • Robert L Zerbe M.D., Independent Chairman of the Board
  • Dominick C. Colangelo, President, Chief Executive Officer, Director
  • Gerard J. Michel, Chief Financial Officer, Vice President - Corporate Development
  • Daniel R. Orlando, Chief Operating Officer, Chief Commercial Officer
  • Ross Tubo, Chief Scientific Officer
  • David Recker M.D., Chief Medical Officer
  • Steven C. Gilman Ph.D., Director
  • Heidi Hagen, Director
  • Kevin F. McLaughlin, Director
  • Paul Kevin Wotton Ph.D., Director

How do I buy Vericel Corp stock?

Shares of Vericel Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vericel Corp's stock price today?

One share of Vericel Corp stock can currently be purchased for approximately $4.20.

MarketBeat Community Rating for Vericel Corp (NASDAQ VCEL)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  116 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about Vericel Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vericel Corp (NASDAQ:VCEL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.33 (50.79% upside)
Consensus Price Target History for Vericel Corp (NASDAQ:VCEL)
Price Target History for Vericel Corp (NASDAQ:VCEL)
Analysts' Ratings History for Vericel Corp (NASDAQ:VCEL)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/2/2017BTIG ResearchSet Price TargetBuy$6.00LowView Rating Details
8/10/2017Piper Jaffray CompaniesReiterated RatingBuy$7.00HighView Rating Details
3/13/2017Needham & Company LLCReiterated RatingBuy -> Buy$9.00 -> $6.00HighView Rating Details
4/5/2016Bank of America CorporationDowngradeBuy -> NeutralN/AView Rating Details
3/12/2016Ladenburg Thalmann Financial ServicesReiterated RatingBuyN/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for Vericel Corp (NASDAQ:VCEL)
Earnings by Quarter for Vericel Corp (NASDAQ:VCEL)
Earnings History by Quarter for Vericel Corp (NASDAQ VCEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.16)N/AView Earnings Details
8/9/2017Q2 2017($0.24)($0.08)$16.95 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.19)($0.31)$9.36 millionViewN/AView Earnings Details
11/7/2016Q3($0.28)($0.38)$10.93 millionViewListenView Earnings Details
5/10/2016Q116($0.25)($0.08)$11.60 million$14.10 millionViewListenView Earnings Details
3/14/2016Q415($0.15)($0.28)$17.36 million$15.40 millionViewListenView Earnings Details
11/13/2015Q315($0.21)($0.26)$10.50 million$11.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.16)$11.31 million$13.60 millionViewListenView Earnings Details
5/14/2015Q115($0.14)($0.27)$11.10 million$10.80 millionViewListenView Earnings Details
3/23/2015Q414($0.47)($0.17)$10.70 million$14.70 millionViewListenView Earnings Details
11/13/2014Q314($0.66)($0.52)$6.73 million$9.66 millionViewN/AView Earnings Details
8/14/2014Q214($1.59)($0.94)$2.50 million$4.43 millionViewN/AView Earnings Details
5/15/2014Q114($0.92)($1.26)ViewN/AView Earnings Details
3/13/2014Q413($1.34)($0.97)$0.02 million$0.01 millionViewN/AView Earnings Details
11/12/2013Q3($2.02)($0.06)ViewListenView Earnings Details
5/8/2013Q1 2013($0.19)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vericel Corp (NASDAQ:VCEL)
Current Year EPS Consensus Estimate: $-0.63 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS


Dividend History for Vericel Corp (NASDAQ:VCEL)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Vericel Corp (NASDAQ:VCEL)
Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 33.84%
Insider Trades by Quarter for Vericel Corp (NASDAQ:VCEL)
Institutional Ownership by Quarter for Vericel Corp (NASDAQ:VCEL)
Insider Trades by Quarter for Vericel Corp (NASDAQ:VCEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2016Consonance Capital ManagementMajor ShareholderSell120,000$5.39$646,800.00View SEC Filing  
9/16/2014Daniel OrlandoCOOBuy9,804$2.55$25,000.20View SEC Filing  
9/16/2014Dominick ColangeloCEOBuy20,000$2.55$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Vericel Corp (NASDAQ:VCEL)
Latest Headlines for Vericel Corp (NASDAQ:VCEL)
Loading headlines, please wait.



Vericel Corp (VCEL) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.